Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. GlaxoSmithKline Biologicals
FDA Inspection
•GlaxoSmithKline Biologicals•March 12, 2024

GlaxoSmithKline Biologicals – FDA Inspection, Mar 12, 2024

Record Details

This FDA Inspection record concerns GlaxoSmithKline Biologicals, with an inspection on March 12, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company
GlaxoSmithKline Biologicals
Inspection Date
March 12, 2024
Product Type
Biologics
Office
Center for Biologics Evaluation and Research
People
  • Latorie S. Jones (FDA Associated Person)
  • Susan M. Jackson (Issuing Officer)
View Company Profile

ID · 70a6a284-2119-4f02-9b73-85f02c66c432

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1232702
FDA center
Biologics
Project area
Vaccines and Allergenic Products

FDA Citations

3
  1. 21 CFR 211.170(b)Annual visual exams of drug products
  2. 21 CFR 211.67(b)(6)Cleaning SOP/inspection
  3. 21 CFR 211.192Investigations of discrepancies, failures

Full citation text and observation details available on the Dashboard.

Other FDA inspections of GlaxoSmithKline Biologicals

3
DateClassificationOfficeProject area
June 4, 2024Not classifiedOffice of Inspections and Investigations
September 13, 2022VAICenter for Biologics Evaluation and ResearchVaccines and Allergenic Products
November 13, 2018Not classifiedOffice of Inspections and Investigations
Other documents for GlaxoSmithKline Biologicals
  • FDA Inspection 1242355 - 2024-06-04
  • FDA Inspection 1179634 - 2022-09-13
  • FDA Inspection 1074672 - 2018-11-13

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore GlaxoSmithKline Biologicals
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.